Message from the President: CIHR Institute of Genetics Scientific Director term renewal


On behalf of Governing Council, I am pleased to announce the renewal of the term of Dr. Paul Lasko as Scientific Director of the Canadian Institutes of Health Research - Institute of Genetics (CIHR-IG), from April 1, 2015 to March 31, 2018.

Since joining CIHR in 2010, Dr. Lasko has provided leadership to the CIHR-IG and two roadmap signature initiatives: the Canadian Epigenetics, Environment and Health Consortium and the Personalized Medicine Initiative. His open collaborative approach has provided new opportunities for CIHR, and strengthened and expanded existing relationships with key partners, like Genome Canada.

Under Dr. Lasko’s direction, the CIHR-IG has continued to champion major research areas such as gene expression and genetic pathways, rare diseases, computational biology and advanced tools and technologies. Notably, Dr. Lasko spearheaded Canada’s efforts to advance rare disease research through CIHR’s active involvement in the International Rare Diseases Research Consortium (IRDiRC), a global collaborative effort of over 18 countries. He has also played a pivotal role in establishing Canada’s lead in the management of the large data sets being generated by the advances made in genomics research. Finally, Dr. Lasko has been a strong advocate for the research community by actively promoting the sustainability of Canadian research here and on the world stage, strengthening networks and collaboration, and developing new and innovative capacity development programs through the Institute.

Dr. Lasko is internationally recognized for his contributions to the fields of developmental genetics and functional genomics. He has received many honours and acclamations, including the 2014 Armand-Frappier Prix du Québec – an award that is considered one of the most prestigious award attributed by the Government of Quebec in cultural and scientific fields.

The work of our Scientific Directors is crucial to achieving CIHR’s objectives and realizing our vision for health research in Canada. As a distinguished scientist and highly respected leader, Dr. Lasko will continue to make important contributions to CIHR and to the valuable work of our scientific community in this second term. Please join me in congratulating him on his renewal.


Alain Beaudet, MD, PhD
Canadian Institutes of Health Research

Date modified: